Global Ketoconazole Cream Market Growth 2026-2032
Description
The global Ketoconazole Cream market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Ketoconazole cream is a broad-spectrum antifungal drug with ketoconazole as its main ingredient. It treats skin problems caused by fungal infections such as tinea manuum, tinea pedis, tinea corporis, tinea cruris, tinea versicolor, and cutaneous candidiasis by inhibiting fungal growth. It can effectively kill a variety of skin fungi and yeasts. However, care should be taken to avoid contact with the eyes when using it. It is contraindicated for those who are allergic to this product and should not be used on large areas.
In 2024, the global production of ketoconazole cream was 92.71 million units, with an average price of US$0.7 per unit.Gross profit margins typically range from 40% to 60%.
The upstream supply chain of ketoconazole cream mainly consists of chemical raw material companies and excipient suppliers, including ketoconazole raw materials, cream base, stabilizers, and packaging materials. The upstream sector is characterized by large-scale and mature operations, with cost fluctuations influenced by raw material chemical prices and regulatory compliance costs, but overall supply is sufficient. The downstream sector is more crucial, primarily encompassing hospitals and retail pharmacies, as well as online drug retail platforms. Prescription demand is influenced by hospital antifungal medication guidelines, medical insurance catalogs, and competition from clinical alternatives, while OTC demand relies on consumer self-purchase demand, brand awareness, and channel coverage. Fungal skin diseases have a high prevalence and recurrence rate globally and in China, ensuring stable downstream demand. Branded drugs and cost-effective generic drugs coexist, with terminal competition focusing on dosage form improvements, reduced skin irritation, and increased accessibility.
Future development trends mainly include increased consumer awareness of self-skin care, continued expansion of OTC channels, and a trend towards more convenient and gentler dermatological medications. New channels, represented by online retail, will continue to improve product accessibility and drive product structure evolution towards branding and differentiation. The driving factors stem from the sustained demand resulting from the stable prevalence and high recurrence rate of fungal infections, as well as the preference for high-quality products following the increasingly standardized regulation of topical dermatological medications. Meanwhile, improvements by companies in cream bases, absorption rates, and skin barrier friendliness are also enhancing product competitiveness. The main obstacles include the strong availability of substitutes for topical antifungal drugs, such as terbinafine and clotrimazole; furthermore, the perception that safety controversies surrounding oral ketoconazole formulations extend to topical formulations in some countries, requiring brands to be more cautious in their advertising. Continued price competition at the retail level may also compress profit margins for branded companies.
LP Information, Inc. (LPI) ' newest research report, the “Ketoconazole Cream Industry Forecast” looks at past sales and reviews total world Ketoconazole Cream sales in 2025, providing a comprehensive analysis by region and market sector of projected Ketoconazole Cream sales for 2026 through 2032. With Ketoconazole Cream sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ketoconazole Cream industry.
This Insight Report provides a comprehensive analysis of the global Ketoconazole Cream landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ketoconazole Cream portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ketoconazole Cream market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ketoconazole Cream and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ketoconazole Cream.
This report presents a comprehensive overview, market shares, and growth opportunities of Ketoconazole Cream market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single-Ingredient Preparations
Combination Preparations
Segmentation by Concentration:
2%
1%
Others
Segmentation by Specifications:
7g
10g
15g
25g
30g
Others
Segmentation by Sales Channels:
Online Sales
Offline Sales
Segmentation by Application:
Tinea Corporis
Tinea Cruris
Tinea Manuum
Tinea Pedis
Tinea Versicolor
Cutaneous Candidiasis
Malassezia Folliculitis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Bayer
Almirall
Teva Pharmaceutical
Viatris
Taro Pharmaceutical Industries
Sandoz
Sun Pharmaceutical
Cipla
Dr. Reddy's
Glenmark Pharmaceuticals
Zydus Lifesciences
Hikma
AdvaCare Pharma
Leeford
Shanghai Baolong Pharmaceutical
Fujian Pacific Pharmaceutical
Hubei Heng'an Fulin Pharmaceutical
Hainan Haiyao
Chengdu Diao Pharmaceutical Group
Shanghai Pharmaceuticals Holding
Henan Lingrui Pharmaceutical
Zhejiang Dingtai Pharmaceutical
Zennova Pharma Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ketoconazole Cream market?
What factors are driving Ketoconazole Cream market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ketoconazole Cream market opportunities vary by end market size?
How does Ketoconazole Cream break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Ketoconazole cream is a broad-spectrum antifungal drug with ketoconazole as its main ingredient. It treats skin problems caused by fungal infections such as tinea manuum, tinea pedis, tinea corporis, tinea cruris, tinea versicolor, and cutaneous candidiasis by inhibiting fungal growth. It can effectively kill a variety of skin fungi and yeasts. However, care should be taken to avoid contact with the eyes when using it. It is contraindicated for those who are allergic to this product and should not be used on large areas.
In 2024, the global production of ketoconazole cream was 92.71 million units, with an average price of US$0.7 per unit.Gross profit margins typically range from 40% to 60%.
The upstream supply chain of ketoconazole cream mainly consists of chemical raw material companies and excipient suppliers, including ketoconazole raw materials, cream base, stabilizers, and packaging materials. The upstream sector is characterized by large-scale and mature operations, with cost fluctuations influenced by raw material chemical prices and regulatory compliance costs, but overall supply is sufficient. The downstream sector is more crucial, primarily encompassing hospitals and retail pharmacies, as well as online drug retail platforms. Prescription demand is influenced by hospital antifungal medication guidelines, medical insurance catalogs, and competition from clinical alternatives, while OTC demand relies on consumer self-purchase demand, brand awareness, and channel coverage. Fungal skin diseases have a high prevalence and recurrence rate globally and in China, ensuring stable downstream demand. Branded drugs and cost-effective generic drugs coexist, with terminal competition focusing on dosage form improvements, reduced skin irritation, and increased accessibility.
Future development trends mainly include increased consumer awareness of self-skin care, continued expansion of OTC channels, and a trend towards more convenient and gentler dermatological medications. New channels, represented by online retail, will continue to improve product accessibility and drive product structure evolution towards branding and differentiation. The driving factors stem from the sustained demand resulting from the stable prevalence and high recurrence rate of fungal infections, as well as the preference for high-quality products following the increasingly standardized regulation of topical dermatological medications. Meanwhile, improvements by companies in cream bases, absorption rates, and skin barrier friendliness are also enhancing product competitiveness. The main obstacles include the strong availability of substitutes for topical antifungal drugs, such as terbinafine and clotrimazole; furthermore, the perception that safety controversies surrounding oral ketoconazole formulations extend to topical formulations in some countries, requiring brands to be more cautious in their advertising. Continued price competition at the retail level may also compress profit margins for branded companies.
LP Information, Inc. (LPI) ' newest research report, the “Ketoconazole Cream Industry Forecast” looks at past sales and reviews total world Ketoconazole Cream sales in 2025, providing a comprehensive analysis by region and market sector of projected Ketoconazole Cream sales for 2026 through 2032. With Ketoconazole Cream sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ketoconazole Cream industry.
This Insight Report provides a comprehensive analysis of the global Ketoconazole Cream landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ketoconazole Cream portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ketoconazole Cream market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ketoconazole Cream and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ketoconazole Cream.
This report presents a comprehensive overview, market shares, and growth opportunities of Ketoconazole Cream market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single-Ingredient Preparations
Combination Preparations
Segmentation by Concentration:
2%
1%
Others
Segmentation by Specifications:
7g
10g
15g
25g
30g
Others
Segmentation by Sales Channels:
Online Sales
Offline Sales
Segmentation by Application:
Tinea Corporis
Tinea Cruris
Tinea Manuum
Tinea Pedis
Tinea Versicolor
Cutaneous Candidiasis
Malassezia Folliculitis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Bayer
Almirall
Teva Pharmaceutical
Viatris
Taro Pharmaceutical Industries
Sandoz
Sun Pharmaceutical
Cipla
Dr. Reddy's
Glenmark Pharmaceuticals
Zydus Lifesciences
Hikma
AdvaCare Pharma
Leeford
Shanghai Baolong Pharmaceutical
Fujian Pacific Pharmaceutical
Hubei Heng'an Fulin Pharmaceutical
Hainan Haiyao
Chengdu Diao Pharmaceutical Group
Shanghai Pharmaceuticals Holding
Henan Lingrui Pharmaceutical
Zhejiang Dingtai Pharmaceutical
Zennova Pharma Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ketoconazole Cream market?
What factors are driving Ketoconazole Cream market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ketoconazole Cream market opportunities vary by end market size?
How does Ketoconazole Cream break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
151 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Ketoconazole Cream by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Ketoconazole Cream by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
